)
New technology helps commercial real estate professionals manage properties and close deals.
)
Whether omicron’s effects prove as damaging as delta remains to be seen. Here is an early look at how the variant complicated the holiday weekend.
)
An analysis of Q3 earnings calls finds many life sciences REITs and developers having excellent years, but face a supply crunch in the immediate future.
)
Despite improvements to the market, the existential shift in the workplace leaves uncertainty in its wake.
)
Developers filed for extensions of 19 approved projects in 2023, a notable increase from prior years as interest rates and construction costs hinder the market.
Owners who have had trouble capitalizing deals may be able to do more of them this year, said Dan Arends, principal and vice chair at Colliers.
)
Most seem to agree the economy will hit a downturn in the next couple of years. But if such a turn will hurt New Jersey industrial, no one seems to know how.
)
No2 Opus Place is supposed to be the tallest residential tower in Atlanta. But shifting stories from a developer with an unsavory reputation have raised doubts.
)
JPMorgan is just the latest company thinking of whittling down its presence in the city.
)
In 2023, the event brought in over 79,000 attendees, generating $109M in economic activity and $8.3 million in local and state taxes.
We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.